Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference Biotech Investing
Innovotech makes strategic investments to expand analytical laboratory services and offers an unsecured convertible debenture for $200,000. Biotech Investing
Acadia Pharmaceuticals to Announce Third Quarter 2025 Financial Results on November 5, 2025 Biotech Investing
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma Biotech Investing
Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025 Biotech Investing
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal Biotech Investing
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption Biotech Investing
PharmaTher Announces KetAImine - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505 NDA Filings Biotech Investing
Summit Therapeutics to Host ESMO Data Update & Third Quarter Earnings Call on October 20, 2025 Biotech Investing
Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference Biotech Investing
